Clinical Trial Supply New England 2020
Following on from another successful conference Arena International will be returning with full force to Waltham in March to celebrate another edition of the Clinical Trial Supply show.
2020 will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, and Blueprint Medicines Corporation. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.
We look forward to seeing you there!
WHAT TO EXPECT FOR 2020?
The Clinical Trial Supply series is a unique platform for clinical trial sponsors and solution providers. This event is aimed at enabling knowledge-sharing, benchmarking and network-building amongst biopharma industry peers.
This is an exceptional networking opportunity for the clinical supply chain industry. Attendees will come from across the Boston pharma hub and beyond to network and make new connections.
Each Clinical Trial Supply conference programme is written in collaboration with the local industry. Our production team will research with senior local leaders to devise an educational programme which meets the needs of that community.
The Clinical Trial Supply exhibition will feature leading solution providers and innovative disruptors to showcase the latest in supply chain management. Attendees will leave with new ideas and new contacts to solve common problems and capitalise on the opportunity that next generation technology offers.
Catalent solves today’s clinical trial challenges and develop innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience reliably supplying thousands of studies of all sizes and complexities around the world.
The programme for the Clinical Trial Supply New England conference is underway. If you have a case study, or key message to deliver to this audience, please contact us below with your proposal.
T: +44 (0) 161 359 5839